Riskpilot← Back to searchSign inGet full accessGedoc AB
ABActiveOrg 5594366832Risängsgatan 15Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20231-4 employees
Revenue 2024
SEK 503K
+597% vs 2023
EBITDA margin
-86.0%
-807% vs 2023
Equity ratio
77.4%
Financial strength
Net profit 2024
SEK -459K
-1047% vs 2023
| Revenue | SEK 503K | +597% |
| EBITDA | SEK -432K | -807% |
| Net profit | SEK -459K | -1047% |
| Total assets | SEK 471K | +224% |
| Equity | SEK 365K | +396% |
| Employees | — | — |
Legal name
Gedoc AB
Org number
5594366832
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1 juni 2023
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska ägna sig åt utveckling och försäljning av medicinteknisk hård- och mjukvara, sjukvårdstjänster, projektledning, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Risängsgatan 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 72 | 503 |
| Staff expenses | — | −0 |
| EBITDA | 61 | −432 |
| Depreciation & amort. | — | −24 |
| EBIT | 61 | −456 |
| Net financials | — | −2 |
| Profit before tax | 61 | −459 |
| Tax | −13 | — |
| Net profit | 48 | −459 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 145 | 471 |
| Equity | 73 | 365 |
| Long-term debt | 50 | 0 |
| Short-term debt | 22 | 106 |
| Total debt | 72 | 106 |
EBITDA margin
-86.0%
This company
15.8%
Market median
-644% vs market
20232024
Equity ratio
77.4%
This company
38.2%
Market median
+103% vs market
20232024
Return on equity
-125.8%
This company
18.4%
Market median
-784% vs market
20232024
Net profit margin
-91.3%
This company
8.1%
Market median
-1227% vs market
20232024
Asset turnover
1.07×
This company
1.12×
Market median
+4% vs market
20232024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20232024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-06-01 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KA Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Chairman | 2025 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gedoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Anders Bülow | Chief Executive Officer | 0 companies |
| John Tomas Bengtsson | Deputy Board Member | 0 companies |
| Andreas Gösta Bengtsson | Board of Directors | 0 companies |
| Andreas Daniel Larsson | Board of Directors | 0 companies |
| Jim Richard Hubner | Board of Directors | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Frank Marcus Sakarias Mårdh | Chairman | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |
| Dan Björkman | Board of Directors | 0 companies |